Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingbin Cui

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Oncology|March 17, 2020
Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer CellsJingqiu Wang, Jing-Quan Wang, Chao-Yun Cai, et al.
Frontiers in Oncology|May 21, 2019
Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer CellsQingbin Cui, Chao-Yun Cai, Hai-Ling Gao, et al.
Cancer Letters|January 15, 2018
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transportersYing-Fang Fan, Wei Zhang, Leli Zeng, et al.
Frontiers in Oncology|November 9, 2020
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 TransporterHai-Ling Gao, Pranav Gupta, Qingbin Cui, et al.
Journal of Cellular Biochemistry|June 11, 2015
A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer CellsLiang Wang, Xiaojing Zhang, Judy Yuet-Wa Chan, et al.
Journal of Medicinal Chemistry|October 18, 2022
Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid SynthaseJenny Beebe, Sophia Josephraj, Chao J Wang, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Oncology|March 17, 2020
Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer CellsJingqiu Wang, Jing-Quan Wang, Chao-Yun Cai, et al.
Frontiers in Oncology|May 21, 2019
Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer CellsQingbin Cui, Chao-Yun Cai, Hai-Ling Gao, et al.
Cancer Letters|January 15, 2018
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transportersYing-Fang Fan, Wei Zhang, Leli Zeng, et al.
Frontiers in Oncology|November 9, 2020
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 TransporterHai-Ling Gao, Pranav Gupta, Qingbin Cui, et al.
Journal of Cellular Biochemistry|June 11, 2015
A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer CellsLiang Wang, Xiaojing Zhang, Judy Yuet-Wa Chan, et al.
Journal of Medicinal Chemistry|October 18, 2022
Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid SynthaseJenny Beebe, Sophia Josephraj, Chao J Wang, et al.
Pageof 5